undamentalytics Newsletter
Sign in

Tela Bio, Inc. revenue

Tela Bio, Inc.'s revenue was $80.3m in fiscal 2025, up 15.8% on the year before. Since fiscal 2017 ($4.2m) it has grown at a compound 44.4% a year. Over the last twelve months it was $79.9m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue481518294158698080
Growth on the year before—+94.9%+86.7%+17.9%+61.8%+40.6%+41.1%+18.6%+15.8%—
Gross profit33911192740465454
Gross margin59.6%35.6%60.0%61.7%63.9%65.3%68.6%67.1%67.7%67.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Tela Bio, Inc. $79.9m 6.1% 17.6%
PRO DEX Inc $79.6m 13.3% 19.2%
Sight Sciences, Inc. $83.4m 9.3% 0.8%
Avita Medical, Inc. $75.6m 1.0% 22.8%
Electromed, Inc. $73.8m 15.3% 15.4%
Pulmonx Corp $87.4m -3.4% 13.0%

Compare with peers

Head to head: PDEX vs TELASGHT vs TELARCEL vs TELAELMD vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Tela Bio, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tela Bio, Inc.